Chen Schor's most recent trade in Adicet Bio Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2026 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Karyopharm Therapeutics Inc | Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 15,508 | 15,508 (0%) | 0% | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 468,555 | 468,555 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 24 Jan 2026 | 1,755 | 6,820 | - | 8.4 | 14,812 | Common Stock |
| Karyopharm Therapeutics Inc | Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 4,600 | 4,600 | - | - | Nonstatutory Stock Option (right to buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 763,829 | 763,829 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 24 Jan 2025 | 28,101 | 137,201 | - | 0.9 | 25,904 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,770,427 | 1,770,427 | - | - | Stock Option (Right to Buy) | |
| Karyopharm Therapeutics Inc | Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Adicet Bio Inc | Schor Chen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 1,116,903 | 1,116,903 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Schor Chen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 70,300 | 208,771 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.40 per share. | 24 Jan 2024 | 15,290 | 138,471 | - | 2.4 | 36,696 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 872,111 | 872,111 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 872,111 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 421,600 | 421,600 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 421,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 384,900 | 384,900 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 384,900 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 295,000 | 295,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 295,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 240,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 36,857 | 36,857 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2023 | 36,857 | 0 | - | - | Stock Option (Right to Buy) | |
| Karyopharm Therapeutics Inc | Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 384,900 | 384,900 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 85,500 | 176,969 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 64,757 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 53,424 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 38,045 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 26,712 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 64,757 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 91,469 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 0 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 26,712 | 26,712 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 9,955 | 48,000 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 9,955 | 43,469 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 10 Nov 2022 | 30,000 | 53,424 | - | 20.1 | 601,920 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 10 Nov 2022 | 9,955 | 91,469 | - | 21.0 | 209,322 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 19.05 per share. | 07 Nov 2022 | 30,000 | 83,424 | - | 19.0 | 571,488 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.04 per share. | 02 Nov 2022 | 24,813 | 113,424 | - | 18.0 | 447,718 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 02 Nov 2022 | 500 | 138,237 | - | 18 | 9,000 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.22 per share. | 04 Oct 2022 | 21,288 | 101,424 | - | 14.2 | 302,715 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 14 Sep 2022 | 952 | 138,737 | - | 18 | 17,136 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.77 per share. | 09 Sep 2022 | 66,747 | 0 | - | 16.8 | 1,119,307 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.51 per share. | 09 Sep 2022 | 8,094 | 66,747 | - | 16.5 | 133,601 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 09 Sep 2022 | 3,371 | 139,689 | - | 18.0 | 60,713 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 09 Sep 2022 | 200 | 143,060 | - | 18 | 3,600 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Aug 2022 | 53,424 | 143,260 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Aug 2022 | 53,424 | 96,000 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 48,000 | 144,000 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.25 per share. | 04 Aug 2022 | 21,288 | 122,712 | - | 18.3 | 388,506 | Common Stock |
| Karyopharm Therapeutics Inc | Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 48,000 | 170,712 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 14 Feb 2022 | 21,288 | 149,424 | - | 14.3 | 303,780 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 48,000 | 144,000 | - | 0 | Common Stock | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.69 per share. | 28 Jan 2022 | 21,288 | 122,712 | - | 11.7 | 248,857 | Common Stock |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 295,000 | 295,000 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Chen Schor | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 240,000 | 240,000 | - | 0 | Common Stock |